Gene Logic, Inc.
Frank L. Douglas joins drug-development company's board of directors
Published in Health Business Week, December 31st, 2004
Douglas has been appointed to fill a vacancy on the board of directors with a term ending at the next annual stockholders meeting, at which time he will be considered for election for a full term.
Until his recent retirement, Douglas was executive vice president, drug innovation & approval and chief scientific officer of Aventis Pharma, AG, where he oversaw Aventis' worldwide pharmaceutical research and development activities and was a member of the board of management of Aventis, SA.
Douglas commented, "Gene Logic's emphasis on providing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2004-12-31)
More Articles from Health Business Week
- Alliance Imaging, Inc.
Imaging firm announces proposed private offering - Allon Therapeutics, Inc.
Company provides pipeline update, completes preclinical studies for AL-108 - AmerisourceBergen Corporation
Pharmaceutical services firm announces new financing, debt redemption - Andromed, Inc.
Device firm completes rights offering - Applied Imaging Corp.
Imaging device firm receives Nasdaq delisting warning - ArthroCare Corp.
Device firm to adjust third quarter results - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
